APA (7th ed.) Citation

Hayato, S., Hasegawa, S., Hojo, S., Okawa, H., Abe, H., Sugisaki, N., . . . Ohnishi, A. (2012). Dose–response relationships of rabeprazole 5, 10, 20, and 40 mg once daily on suppression of gastric acid secretion through the night in healthy Japanese individuals with different CYP2C19 genotypes. European journal of clinical pharmacology, 68(5), 579-588. https://doi.org/10.1007/s00228-011-1164-7

Chicago Style (17th ed.) Citation

Hayato, Seiichi, Setsuo Hasegawa, Seiichiro Hojo, Hiroki Okawa, Hiroaki Abe, Nobuyuki Sugisaki, Masahiro Munesue, Yukio Horai, and Akihiro Ohnishi. "Dose–response Relationships of Rabeprazole 5, 10, 20, and 40 mg Once Daily on Suppression of Gastric Acid Secretion Through the Night in Healthy Japanese Individuals with Different CYP2C19 Genotypes." European Journal of Clinical Pharmacology 68, no. 5 (2012): 579-588. https://doi.org/10.1007/s00228-011-1164-7.

MLA (9th ed.) Citation

Hayato, Seiichi, et al. "Dose–response Relationships of Rabeprazole 5, 10, 20, and 40 mg Once Daily on Suppression of Gastric Acid Secretion Through the Night in Healthy Japanese Individuals with Different CYP2C19 Genotypes." European Journal of Clinical Pharmacology, vol. 68, no. 5, 2012, pp. 579-588, https://doi.org/10.1007/s00228-011-1164-7.